Sponsors (2)
The bill tightens border enforcement to keep noncompliant and potentially unsafe dietary products out of the U.S., improving consumer safety, but it raises compliance burdens, legal exposure, and enforcement costs for businesses and taxpayers.
Consumers — including patients with chronic conditions and uninsured individuals — will face fewer unsafe or mislabeled dietary supplements at the border because FDA and Customs would have clearer authority to detain, refuse admission, or seize products that do not meet the statutory definition.
Consumers broadly benefit from reduced risk that supplements made with the involvement of debarred persons enter the market, improving product safety and industry accountability.
Federal, state, and local regulators gain clearer legal tools to enforce supplement standards at ports of entry, enabling more consistent enforcement actions.
Manufacturers and importers — including many small businesses — face greater compliance risk and potential financial losses if products are reclassified or seized, which could reduce supply and raise prices for consumers.
Companies may face penalties or legal exposure for supply-chain involvement with debarred persons even when they lacked knowledge, increasing litigation risk and business uncertainty.
Taxpayers and industry may shoulder higher administrative and enforcement costs as seizures and import refusals increase.
Based on analysis of 2 sections of legislative text.
Makes products misidentified as dietary supplements or handled with help from debarred persons unlawful in interstate commerce and authorizes refusal of entry and seizure.
Introduced February 5, 2026 by Richard Joseph Durbin · Last progress February 5, 2026
Creates two new federal prohibitions that bar certain products from interstate commerce: (1) any product marketed as a "dietary supplement" that does not meet the statutory definition of dietary supplement, and (2) any dietary supplement prepared, packed, or held with the assistance of, or at the direction of, a person who has been debarred under the Food, Drug, and Cosmetic Act. It also makes those products subject to refusal of entry at U.S. borders and expands seizure authority so FDA/Customs can refuse or seize such shipments. The bill therefore tightens rules for supplement makers, importers, distributors, and anyone previously debarred from FDA-regulated work.